Meningococcal meningitis
ORPHA:33475DiseaseNot applicableAll ages
Фенотипы (HPO)35
Очень частый (80–99%)6
HP:0001945Fever
HP:0002922Increased CSF protein concentration
HP:0011972Hypoglycorrhachia
HP:0012229CSF pleocytosis
HP:0025258Stiff neck
HP:0031179Nuchal rigidity
Частый (30–79%)9
HP:0000613Photophobia
HP:0000967Petechiae
HP:0000988Skin rash
HP:0002039Anorexia
HP:0002315Headache
HP:0002587Projectile vomiting
HP:0004372Reduced consciousness/confusion
HP:0011227Elevated circulating C-reactive protein concentration
HP:0100806Sepsis
Периодический (5–29%)13
HP:0000083Renal insufficiency
HP:0000236Abnormality of the anterior fontanelle
HP:0000365Hearing impairment
HP:0000737Irritability
HP:0000979Purpura
HP:0001085Papilledema
HP:0001250Seizure
HP:0001254Lethargy
HP:0002329Drowsiness
HP:0002516Increased intracranial pressure
HP:0002615Hypotension
HP:0003401Paresthesia
HP:0032308Increased circulating procalcitonin concentration
Очень редкий (1–4%)7
HP:0001297Stroke
HP:0002045Hypothermia
HP:0002383Infectious encephalitis
HP:0002643Neonatal respiratory distress
HP:0006824Cranial nerve paralysis
HP:0011880Acute disseminated intravascular coagulation
HP:0031273Shock
Эпидемиология4
| Тип оценки | Класс распространённости | Среднее (на 100к) | Регион | Квалификация |
|---|---|---|---|---|
| Point prevalence | 1-9 / 100 000 | — | Europe | Class only |
| Annual incidence | 1-9 / 100 000 | 2.3 | France | Value and class |
| Annual incidence | 1-9 / 100 000 | 2.7 | New Zealand | Value and class |
| Annual incidence | 1-9 / 1 000 000 | 0.8 | United States | Value and class |
Лекарства и терапия
Источник: Open Targets Platform (в реальном времени)
Клинические исследования
Источник: ClinicalTrials.gov (в реальном времени)